BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/11/2024 2:23:39 AM | Browse: 216 | Download: 694
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 91413
Country Portugal
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Colorectal cancer screening: A review of current knowledge and progress in research
Manuscript Source Invited Manuscript
All Author List Sara Ramos Lopes, Claudio Martins, Inês Costa Santos, Madalena Teixeira, Élia Gamito and Ana Luisa Alves
ORCID
Author(s) ORCID Number
Sara Ramos Lopes http://orcid.org/0009-0009-6207-7437
Claudio Martins http://orcid.org/0000-0002-0038-2833
Élia Gamito http://orcid.org/0000-0002-4634-9035
Ana Luisa Alves http://orcid.org/0000-0001-5536-3659
Funding Agency and Grant Number
Corresponding Author Claudio Martins, MD, Doctor, Doctor, Department of Gastroenterology, Centro Hospitalar de Setúbal, Rua Camilo Castelo Branco, Setúbal 2910-446, Portugal. cmartins1@campus.ul.pt
Key Words Colorectal cancer; Screening; Review; Oncology; Artificial intelligence
Core Tip Despite progress in screening and early diagnosis, a significant proportion (approximately 20%-25%) of patients diagnosed with colorectal cancer still exhibit metastatic disease at the time of their initial diagnosis. Various screening tests are available, differing in invasiveness and preparation requirements. Nevertheless, adherence rates remain suboptimal. While new and promising methods are emerging to address these challenges, further research is needed before its integration in clinical practice.
Publish Date 2024-04-11 02:23
Citation Lopes SR, Martins C, Santos IC, Teixeira M, Gamito É, Alves AL. Colorectal cancer screening: A review of current knowledge and progress in research. World J Gastrointest Oncol 2024; 16(4): 1119-1133
URL https://www.wjgnet.com/1948-5204/full/v16/i4/1119.htm
DOI https://dx.doi.org/10.4251/wjgo.v16.i4.1119
Full Article (PDF) WJGO-16-1119-with-cover.pdf